About Sang Gyun Kim
Form D filings for Ingenia Therapeutics in 2024 list Sang Gyun Kim as director.
Sang Gyun Kim first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Sang Gyun Kim in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sang Gyun Kim works with at each company, as listed on that company's latest Form D.
Ingenia Therapeutics Inc. · Form D, Jun 21, 2024
EF
Eric Furfine
Director
JK
Joo Hee Kwak
Director
SH
Sangyeul Han
President and director
KC
Kwang Ho Cheong
Director